-transparent.png){kind=logo}
Suppression and/or cytotoxicity are believed to play an important role in the defense against Epstein-Barr virus (EBV) infection. To analyze the role of suppressor T cells in relation to EBV, we sought to clone and study these T cells. Analysis of 152 T cell clones derived from the peripheral blood of two patients with acute EBV-induced infectious mononucleosis (IM) yielded 11 highly suppressive clones that had no cytotoxic activity for the natural killer sensitive K562 cell line, an autologous EBV-infected cell line, or an allogeneic EBV-infected B cell line. Four of six suppressor T cell clones also profoundly inhibited EBV-induced immunoglobulin production, and five of five clones delayed the outgrowth of immortalized cells. These results indicate that during acute IM, suppressor T cells capable of inhibiting B cell activation in the absence of cytotoxicity can be identified, and may play a key role in the control of EBV infection.
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
November 1979,
The New England journal of medicine,
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
November 1979,
Journal of immunology (Baltimore, Md. : 1950),
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
October 1990,
The Journal of clinical investigation,
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
February 2001,
Clinical otolaryngology and allied sciences,
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
March 1971,
Hippokrates,
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
October 2004,
American family physician,
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
August 2017,
Chinese medical journal,
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
June 2000,
Current opinion in pediatrics,
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
September 2012,
Medical oncology (Northwood, London, England),
F Wang, and
R M Blaese, and
K C Zoon, and
G Tosato
October 1985,
Clinical immunology and immunopathology,
